Alembic Pharmaceuticals

quarterly
yearly
ParticularsJun '24Sep '24Dec '24Mar '25Jun '25
Revenue1,4791,5961,4221,5841,502
Expenses1,2661,4091,3181,4921,376
EBITDA294.57275.55195.29183.87221.53
EBIT225.89218.30125.60115.27148.16
Profit Before Tax213.20200.02103.8191.56125.52
Net Profit176.19165.7885.8175.34103.52
Financial Ratios
Operating Profit Margin19.96%18.25%13.89%11.71%14.83%
Net Profit Margin11.94%9.81%6.10%4.80%6.93%
Earning Per Share (Diluted)8.968.434.373.835.27
Dividends Per Share0.000.000.000.000.00